Reinforcement Learning for Personalized Drug Discovery and Design for
  Complex Diseases: A Systems Pharmacology Perspective
  Many multi-genic systemic diseases such as neurological disorders,
inflammatory diseases, and the majority of cancers do not have effective
treatments yet. Reinforcement learning powered systems pharmacology is a
potentially effective approach to design personalized therapies for untreatable
complex diseases. In this survey, state-of-the-art reinforcement learning
methods and their latest applications to drug design are reviewed. The
challenges on harnessing reinforcement learning for systems pharmacology and
personalized medicine are discussed. Potential solutions to overcome the
challenges are proposed. In spite of successful application of advanced
reinforcement learning techniques to target-based drug discovery, new
reinforcement learning strategies are needed to address systems
pharmacology-oriented personalized de novo drug design.
